Header Logo

Connection

Theodore Levin to Risk Assessment

Back to Details
This is a "connection" page, showing publications Theodore Levin has written about Risk Assessment.
Theodore Levin
Connection Strength
0.571
Risk Assessment
  1. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
    View in: PubMed
    Score: 0.132
  2. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012 Sep; 143(3):844-857.
    View in: PubMed
    Score: 0.076
  3. What does sigmoidoscopy really miss? Am J Gastroenterol. 2003 Oct; 98(10):2326-7.
    View in: PubMed
    Score: 0.041
  4. Re: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003 Jun 04; 95(11):830-1; author reply 831.
    View in: PubMed
    Score: 0.040
  5. Could screening for colorectal cancer be harmful? Am J Gastroenterol. 2002 Jan; 97(1):198.
    View in: PubMed
    Score: 0.037
  6. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.032
  7. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.031
  8. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 Jul; 112(7):1016-1030.
    View in: PubMed
    Score: 0.027
  9. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):85-94.
    View in: PubMed
    Score: 0.025
  10. Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2016 Mar; 150(3):758-768.e11.
    View in: PubMed
    Score: 0.024
  11. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2014 Aug; 80(2):197-220.
    View in: PubMed
    Score: 0.022
  12. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2014 Aug; 147(2):502-26.
    View in: PubMed
    Score: 0.022
  13. Implications of new colorectal cancer screening technologies for primary care practice. Med Care. 2008 Sep; 46(9 Suppl 1):S138-46.
    View in: PubMed
    Score: 0.015
  14. Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study. Drug Saf. 2008; 31(4):325-34.
    View in: PubMed
    Score: 0.014
  15. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.014
  16. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003 Feb; 124(2):544-60.
    View in: PubMed
    Score: 0.010
  17. Gastric and duodenal safety of daily alendronate. Arch Intern Med. 2002 Apr 22; 162(8):936-42.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente